Evidence map›Paper›PMID 31416845›Full record

ArticleCancer research2019

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells.

Junko Mukohyama, Taichi Isobe, Qingjiang Hu, Takanori Hayashi, Takashi Watanabe, Masao Maeda, Hisano Yanagi, Xin Qian, Kimihiro Yamashita, Hironobu Minami and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 80 citations in OpenAlex.

  1. Review
  2. Recent advancements and limitations of intestinal organoids for clinical applications.Progress in biomedical engineering (Bristol, England) · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. RNA-binding proteins regulating the CD44 alternative splicing.Frontiers in molecular biosciences · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Application Progress of Organoids in Colorectal Cancer.Frontiers in cell and developmental biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Junko MukohyamaDivision of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Taichi IsobeInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California.
Qingjiang HuDepartment of Surgery and Science, Kyushu University Hospital, Fukuoka, Japan.
Takanori HayashiDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Takashi WatanabeDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Masao MaedaDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Hisano YanagiDepartment of Biochemistry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
Xin QianInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California.ORCID 0000-0002-8285-6368
Kimihiro YamashitaDivision of Gastrointestinal Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Hironobu MinamiDivision of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Koshi MimoriDepartment of Surgery, Kyushu University Beppu Hospital, Beppu, Oita, Japan.ORCID 0000-0003-3897-9974
Debashis SahooDepartment of Computer Science and Engineering, Department of Pediatrics, University of California San Diego (UCSD), San Diego, California.
Yoshihiro KakejiDivision of Gastrointestinal Surgery, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.ORCID 0000-0002-2727-0241
Akira SuzukiDivision of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Piero DalerbaDepartment of Pathology and Cell Biology, Department of Medicine (Division of Digestive and Liver Diseases), Herbert Irving Comprehensive Cancer Center (HICCC) and Columbia Stem Cell Initiative (CSCI), Columbia University, New York, New York.ORCID 0000-0002-8815-4981
Yohei ShimonoDivision of Molecular and Cellular Biology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan. yshimono@fujita-hu.ac.jp.ORCID 0000-0002-6256-4704
Fujita Health University · JPKobe University · JPCalifornia Institute for Regenerative Medicine · USColumbia University Irving Medical Center · USKyushu University Beppu Hospital · JPKyushu University Hospital · JPUniversity of California San Diego · US

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI Anil K Rustgi · 1985 to 2026
$115.3M
BD Biosciences InfluxS10OD020056 · OD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SNOECK, HANS-WILLEM E · 2015 to 2015
$600k
NCI NIH HHS P30 CA013696NIH HHS S10 OD020056
6 · The paper itself

Abstract

miRNAs are key players in the integrated regulation of cellular processes and shape many of the functional properties that define the "cancer stem cell" (CSC) phenotype. Little is known, however, about miRNAs that regulate such properties in human colorectal carcinoma. In this study, we compared the expression levels of 754 miRNAs between paired samples of EpCAM

Indexed as

Gene Expression Regulation, Neoplastic3' Untranslated RegionsAdenocarcinomaAnimalsCell Line, TumorColorectal NeoplasmsGenes, ReporterHeterograftsHumansMiceMice, Inbred NODMice, SCIDMicroRNAsNeoplasm ProteinsNeoplasm TransplantationNeoplastic Stem Cells3' Untranslated RegionsMicroRNAsMIR221, humanNeoplasm ProteinsProtein IsoformsRecombinant ProteinsRNA-binding protein QKI-5, humanRNA-Binding ProteinsRNA, Neoplasm

Identifiers

PMID31416845
PMCPMC6801097
OpenAlexW2967649110

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.